Insider transactions

EDGAR

Decibel Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

No holding was reported in this window.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BlackRock, Inc. Common Stock7.21,805,108— Filed 2023-02-03SC 13GRead from the cover page textOpen filing 0001306550-23-006964 Dispute this row
GV 2016, L.P. Common Stock, par value $0.001 per share1.29321,978— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2016 GP, L.P. Common Stock, par value $0.001 per share1.29321,978— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2016 GP, L.L.C. Common Stock, par value $0.001 per share1.29321,978— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2017, L.P. Common Stock, par value $0.001 per share1.98494,649— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2017 GP, L.P. Common Stock, par value $0.001 per share1.98494,649— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2017 GP, L.L.C. Common Stock, par value $0.001 per share1.98494,649— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2019, L.P. Common Stock, par value $0.001 per share3.29819,631— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2019 GP, L.P. Common Stock, par value $0.001 per share3.29819,631— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
GV 2019 GP, L.L.C. Common Stock, par value $0.001 per share3.29819,631— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
Alphabet Holdings LLC Common Stock, par value $0.001 per share6.571,636,258— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
XXVI Holdings Inc. Common Stock, par value $0.001 per share6.571,636,258— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
Alphabet Inc. Common Stock, par value $0.001 per share6.571,636,258— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-040723 Dispute this row
Third Rock Ventures III, L.P. COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
Third Rock Ventures GP III, L.P. COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
TRV GP III, LLC COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
Mark Levin COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
Kevin P. Starr COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
Robert I. Tepper COMMON STOCK, $0.001 PAR VALUE PER SHARE12.63,139,685— Filed 2022-02-14SC 13GRead from the cover page textOpen filing 0001193125-22-042110 Dispute this row
REGENERON PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share8.422,097,314— Filed 2022-02-11SC 13GRead from the cover page textOpen filing 0001104659-22-020463 Dispute this row
OrbiMed Advisors LLC Common Stock16.74,061,774— Filed 2021-03-02SC 13DRead from the cover page textOpen filing 0000947871-21-000278 Dispute this row
OrbiMed Capital GP VIII LLC Common Stock15.83,843,206— Filed 2021-03-02SC 13DRead from the cover page textOpen filing 0000947871-21-000278 Dispute this row
OrbiMed Genesis GP LLC Common Stock0.9218,568— Filed 2021-03-02SC 13DRead from the cover page textOpen filing 0000947871-21-000278 Dispute this row
OrbiMed Capital LLC Common Stock3.6883,418— Filed 2021-03-02SC 13DRead from the cover page textOpen filing 0000947871-21-000278 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015246,723
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to Decibel Therapeutics, Inc.